LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-19
Case ID: NM_032043.3_c.2593C_T_20260819_073942
Framework: ACMG/AMP 2015
Variant classification summary

NM_032043.3:c.2593C>T

BRIP1  · NP_114432.2:p.(Arg865Trp)  · NM_032043.3
GRCh37: chr17:59763509 G>A  ·  GRCh38: chr17:61686148 G>A
Gene: BRIP1 Transcript: NM_032043.3
Final call
VUS
PM2 supporting PP3 moderate
All criteria require review: For research and educational purposes only.
Gene
BRIP1
Transcript
NM_032043.3
Protein
NP_114432.2:p.(Arg865Trp)
gnomAD AF
2.6642411745462117e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): variant is present but extremely rare in gnomAD (v4.1 total allele frequency 2.66e-05), below the 0.1% rarity threshold.
2
PP3 (Moderate): REVEL score 0.804 falls within the ClinGen-calibrated Pathogenic Moderate band (>=0.773).
3
PM2 (supporting) plus PP3 (moderate) satisfies no generic ACMG/AMP 2015 combining rule, so the variant is classified as VUS.
Final determination: Generic ACMG/AMP 2015 fallback combining rules require thresholds like (1 PS+1 PM), (3 PM), (2 PS) etc. for LP/P and (1 BS+1 BP)/(2 BP) for LB; 1 PM2-supporting + 1 PP3-moderate meets none, so VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: this missense substitution triggers no null-variant mechanism such as nonsense-mediated decay.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not assessed Not assessed: no alternate nucleotide change producing the identical p.Arg865Trp change with an established pathogenic classification was available.
PS2 Not assessed Not assessed: no proband phenotype, parental genotypes, or parentage confirmation were available for this variant.
clinvar PMID:25741868
PS3 Not assessed Not assessed: no validated functional assay data on this variant were found in any cited publication.
PS4 Not assessed Not assessed: no case-control dataset reported carrier counts for this variant in affected individuals versus controls.
clinvar
PM1 Not met Not met: Cancerhotspots.org returned no statistically significant hotspot at residue 865.
PMID:31822495
PM2 Met Met (supporting): gnomAD v4.1 total allele frequency is 2.66e-05 (43/1,613,968), below the 0.1% PM2 threshold.
gnomad_v4 gnomad_v2 gnomad_canada
PM3 Not assessed Not assessed: no affected individual carrying this variant together with a second pathogenic BRIP1 allele was reported.
clinvar
PM4 N/A Not applicable: missense substitution produces no change in protein length.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not assessed Not assessed: no alternate missense change at codon 865 with an established pathogenic classification was identified.
PM6 Not assessed Not assessed: no report of this variant arising de novo in a proband with confirmed parental samples was available.
clinvar PMID:25741868
PP1 Not assessed Not assessed: no evaluable family segregation data were available.
clinvar
PP2 Not assessed Not assessed: missense is a recognized BRIP1 disease mechanism, but no missense constraint metric was available.
PMID:31822495
PP3 Met Met (moderate): REVEL score 0.804 falls in the ClinGen-calibrated Pathogenic Moderate band (>=0.773).
revel
PP4 Not assessed Not assessed: no proband phenotype data demonstrating specificity for a BRIP1-related disorder were available.
PP5 Not met Not met: the ClinVar record lacks expert-panel submissions and is classified as uncertain significance by laboratory submitters.
clinvar
BA1 Not met Not met: highest gnomAD v4.1 population allele frequency is 3.29e-05, far below the 5% BA1 threshold.
gnomad_v4 gnomad_v2
BS1 Not met Not met: gnomAD allele frequencies (maximum 3.29e-05) are below the 0.3% BS1 threshold.
gnomad_v4 gnomad_v2
BS2 Not assessed Not assessed: no phenotype- and age-ascertained observations of this variant in healthy adults were available.
gnomad_v4 gnomad_v2
BS3 Not assessed Not assessed: no functional assay evidence of normal protein activity for this variant was found.
BS4 Not assessed Not assessed: the reported lack of co-segregation in one family was insufficiently documented to establish non-segregation.
clinvar
BP1 Not met Not met: BRIP1 missense variants are an established disease mechanism, so missense cannot be presumed benign.
PMID:31822495
BP2 Not assessed Not assessed: no observation placed this variant in cis or trans with a pathogenic allele.
clinvar
BP3 N/A Not applicable: this is a missense substitution, not an in-frame indel in a repetitive region.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: REVEL 0.804 falls in the pathogenic direction, so no benign in-silico evidence applies.
revel spliceai
BP5 Not assessed Not assessed: no data established that the phenotype is explained by an alternative molecular diagnosis.
BP6 Not met Not met: the ClinVar record has no expert-panel Benign/Likely benign assertion.
clinvar
BP7 N/A Not applicable: this is a missense substitution, not a synonymous variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.